The Manila Times

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control ...
The Daily Pennsylvanian

Penn Medicine, CHOP to begin testing specialized gene therapy after working on new FDA protocol

Penn Medicine and the Children's Hospital of Philadelphia will begin testing a new gene therapy for rare diseases following the release of a new Food and Drug Administration protocol on Nov. 12. Penn ...
Seeking Alpha

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal ...

LEXINGTON, Mass.--(BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (ALDX) (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and Drug ...

New research identifies key strategies for global drug safety studies

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Nature

Medication Administration Via Enteral Feeding Tubes

The administration of medications via enteral feeding tubes is a vital practice in the care of patients who are unable to ingest drugs orally. This route enables the delivery of essential treatments ...